Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice

Recruiting Observational Study
Coronary Artery Disease Coronary Artery Disease (Left Main) Chronic Total Occlusion (CTO) Bifurcation Coronary Artery Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
11,092 (estimated)
Sponsor
Cathreine BV · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Coronary artery disease remains a leading cause of mortality worldwide and is commonly treated with percutaneous coronary intervention (PCI). Typically, PCI is guided by invasive coronary angiography (ICA). However, ICA has inherent limitations in accurately assessing vessel dimensions, calcium burden, circumferential tissue and whether a stent has achieved full expansion. Therefore ICA alone is i…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients above the age of 18, included in the Netherlands Heart Registration (NHR) quality database after receiving PCI in complex coronary lesions, will be included in the analyses of this project. * Meeting one or more of the following complexity criteria: * Left main…
Contacts

Koen Teeuwen, MD PhD

+ 31 040 239 9111

koen.teeuwen@catharinaziekenhuis.nl

CONTACT

Konrad AJ van Beek, MD

+ 31 040 239 9111

konrad.v.beek@catharinaziekenhuis.nl

CONTACT